Standard BioTools Inc.

DB:FLB Stock Report

Market Cap: €368.6m

Standard BioTools Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:FLB Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Dec 25Buy€430,954Casdin Capital, LLCCompany350,000€1.24
25 Nov 25Buy€8,690,055Casdin Capital, LLCCompany7,700,000€1.24
20 Nov 25Buy€1,191,207Casdin Capital, LLCCompany1,075,000€1.13
17 Nov 25Buy€971,505Casdin Capital, LLCCompany925,000€1.07
12 Nov 25Buy€1,189,799Casdin Capital, LLCCompany1,175,000€1.03
09 Sep 25Buy€110,007Casdin Capital, LLCCompany100,000€1.10
04 Sep 25Buy€546,173Casdin Capital, LLCCompany500,000€1.10
26 Aug 25Buy€565,182Casdin Capital, LLCCompany525,000€1.08
15 Aug 25Buy€378,350Casdin Capital, LLCCompany358,220€1.12
23 May 25Sell€10,973Sean MackayIndividual13,217€0.83
23 May 25Sell€1,186Hanjoon KimIndividual1,428€0.83
23 May 25Sell€4,544Michael EgholmIndividual5,473€0.83
22 May 25Sell€22,853Sean MackayIndividual25,374€0.91
22 May 25Sell€4,543Michael EgholmIndividual5,116€0.89
22 May 25Sell€1,203Hanjoon KimIndividual1,355€0.89
21 May 25Sell€1,278Hanjoon KimIndividual1,407€0.91
21 May 25Sell€4,287Michael EgholmIndividual4,719€0.91
28 Feb 25Buy€4,934,596Casdin Capital, LLCCompany4,820,959€1.02

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of FLB?
Owner TypeNumber of SharesOwnership Percentage
Public Companies16,5150.00429%
Individual Insiders5,590,0071.45%
Hedge Funds78,618,73520.4%
General Public79,180,26620.6%
VC/PE Firms88,783,85623.1%
Institutions132,376,03534.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 75.04% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
23.1%
Casdin Capital, LLC
88,783,856€85.1m14.5%6.75%
15.3%
Viking Global Investors LP
58,651,170€56.2m0%0.18%
6.64%
BlackRock, Inc.
25,515,933€24.5m2.39%no data
5.19%
MAK Capital One, LLC
19,967,565€19.1m3.52%2.56%
4.5%
The Vanguard Group, Inc.
17,297,599€16.6m0.3%no data
3.3%
Long Focus Capital Management LLC
12,678,403€12.2m11.6%0.72%
1.93%
Geode Capital Management, LLC
7,420,696€7.1m-0.65%no data
1.88%
Morgan Stanley Investment Management Inc.
7,232,924€6.9m28.2%0.01%
1.69%
State Street Global Advisors, Inc.
6,482,766€6.2m1.25%no data
1.44%
Hollow Brook Wealth Management LLC
5,553,381€5.3m-3.85%1.49%
1.2%
Neuberger Berman Investment Advisers LLC
4,624,465€4.4m-2.14%no data
1.13%
Amova Asset Management Co., Ltd.
4,335,887€4.2m-19.6%no data
0.92%
Tikvah Management LLC
3,551,152€3.4m0%1.1%
0.88%
Millennium Management LLC
3,387,428€3.2m133%no data
0.8%
Barclays PLC
3,080,414€3.0m-2.95%no data
0.8%
ARK Investment Management LLC
3,066,665€2.9m1.49%0.02%
0.75%
Royce & Associates, LP
2,885,529€2.8m2.88%0.03%
0.72%
Eli Casdin
2,786,050€2.7m1.06%no data
0.65%
Charles Schwab Investment Management, Inc.
2,508,064€2.4m0.16%no data
0.62%
Northern Trust Global Investments
2,390,544€2.3m-7.84%no data
0.49%
Pivotal BioVenture Partners LLC
1,883,179€1.8m0%0.49%
0.42%
Slate Path Capital LP
1,615,000€1.5m0%0.02%
0.28%
Citadel Advisors LLC
1,076,361€1.0m120%no data
0.27%
Michael Egholm
1,027,316€984.8k7.68%no data
0.21%
BNY Asset Management
793,599€760.7k-0.57%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/23 23:46
End of Day Share Price 2026/02/23 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Standard BioTools Inc. is covered by 13 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Paul KnightBrean Capital Historical (Janney Montgomery)
Sung Ji NamBTIG
Bryan BrokmeierCantor Fitzgerald & Co.